Embed Size (px)
Citation preview
1
Financial Statements for the 3rd quarter of fiscal year ending March 31, 2017
(From Apr. 1, 2016 to Dec. 31, 2016)
Summary of consolidated results
Company Code No. 7702 JMS Co., Ltd.
February 10, 2017
2
Sales
Japan
-Increased sales of Enteral nutrition system products -Increased sales of Blood bags with leukocyte reduction filter
Overseas
-Decreased sales of AV fistula needles -Adverse influence of the strong yen in foreign currency translation
Profit
-Increase in profit, despite the increase of depreciation burden for large-scale investment -Favorable foreign exchange conditions
Apr. - Dec. 2015 Results
Apr. - Dec. 2016 Results Diff. Year– over – Year
Sales 43,095 41,773 (1,321) (3.1%)
Operating Income 1,019 1,053 34 3.4%
Ordinary Income 959 1,397 437 45.6% Profit attributable to owners of parent 721 1,174 452 62.7%
Net Income per share JPY 14.81 JPY 24.09 --- ---
Decreased in sales, but increased in profit(2nd straight year) for the 3rd Quarter of FYE Mar. 2017
Highlights in Business Results (unit: JPY million)
Exchange Rate (average during period)
US Dollar 121.70 106.63
Euro 134.77 121.17
Singapore Dollar 88.20 77.60 (unit: JPY)
3
15,522
3,062 2,410 2,473 1,426
7,929
1,224 2,409 2,473 1,426
13,740
2,995 2,224 1,783 1,216
6,808
1,232 2,221 1,783 1,216
Apr. – Dec. 2015 Apr. – Dec. 2016 (unit: JPY million)
Sales by segment (geographical area)
27,632 28,511
30,811 31,487 Sales incl. internal transaction
Japan Southeast Asia China Germany United States Others 0
5,000
10,000
15,000
25,000
30,000
Sales for third party
4
(9)
672
(109)
222
102
(230)
585 603
315
68 66
(389) (400)
(200)
0
200
400
600
800(unit: JPY million)
Japan Southeast Asia China Germany United States Others
Profit by segment (geographical area)
Apr. – Dec. 2015 Apr. – Dec. 2016
5
Sales 31,487 JPY mil.
Ordinary Income 585 JPY mil.
Sales 2,995 JPY mil.
Ordinary Income 315 JPY mil.
Japan
2.2%
－%
(11.5%)
(10.2%)
(2.2%)
－%
Sales 13,740 JPY mil.
Ordinary Income 603 JPY mil.
Southeast Asia
China
-Decreased sales of AV fistula needles for North America market as well as strong yen in yen translation , reduced net sales -Higher import cost with weak SGD resulted in a profit decrease
-Increased sales of Infusion Sets for Japan market was offset by decrease in yen translation with strong yen, reducing net sales -The influence of sales increase on a local currency basis led to a profit increase
Summary by segment (geographical area)
-Increased sales of Enteral nutrition system products raised net sales -The increase of depreciation burden was offset by the sales increase effect, leading to a profit increase
( %: year-over-year )
Enteral Nutrition Systems is designed for use when providing nutrition treatment (which uses a tube to send nutrients directly into the patient's body) to patients who have difficulty absorbing nutrients through standard meals.
Enteral Nutrition Systems
6
-Increased sales of Blood bags for Russia market was offset by decrease in yen translation with strong yen, reducing net sales -Higher import cost with weak Euro resulted in a profit decrease
Sales 2,224 JPY mil.
Ordinary Income 68 JPY mil.
Sales 1,783 JPY mil.
Ordinary Income 66 JPY mil.
Sales 1,216 JPY mil.
Ordinary Ioss (389) JPY mil.
-Decreased sales of AV fistula needles for North America market reduced net sales -The influence of decreased sales resulted in a profit decrease
(7.7%)
(69.3%)
(27.9%)
(34.6%)
(14.7%)
－ %
United States
Others
Germany
Summary by segment (geographical area)
( %: year-over-year )
Blood bag is used for collection, storage and transfusion of blood.
Blood bags
7
21,032
13,421
3,528 3,626 1,486
20,867
12,669
3,174 3,746
1,315
0
5,000
10,000
15,000
20,000
25,000
Apr. – Dec. 2015 Apr. – Dec. 2016
(unit: JPY million)
Infusion and Transfusion
Dialysis General Medical Supplies
Cardiovascular Others
Sales by Business Segment
8
27,310
5,061
3,310
5,899
1,513
28,082
4,772
3,033 4,820
1,065 0
5,000
10,000
15,000
20,000
25,000
30,000
Apr. – Dec. 2016
Apr. – Dec. 2015 Apr. – Dec. 2016
(unit: JPY million)
Japan North America Asia・Oceania Others Europe
Sales by Segment (Customer's Location)
Japan 67%
Asia・Oceania 12%
Others 3%
Europe 7%
North America 11%
9
Apr. - Dec. 2015
Apr. - Dec. 2016 Diff.
Year -over- Year
Labor Cost 4,349 4,291 (58) (1.3%)
Transport 1,234 1,186 (48) (3.9%)
R & D 868 1,105 237 27.3%
Depreciation 309 287 (21) (6.9%)
Others 3,300 3,082 (218) (6.6%)
Total 10,062 9,953 (109) (1.1%)
(unit: JPY million)
(unit: JPY million)
Selling, General and Admin. Expenses
Apr. - Dec. 2015
Apr. - Dec. 2016
10,062 9,953
23.3% 23.8%
0%
10%
20%
30%
40%
0
3,000
6,000
9,000
12,000
10
Ordinary Income: Compared with the previous year
Ordinary income increased
JPY 438 million
Ordinary Income
Apr.-Dec. 2015
Ordinary Income
Apr.-Dec. 2016
(unit: JPY million)
Impact of Exchange rate
Increase of Gross Profit
Increase of Non-operating profit
Increase of SGA
The underlined figures exclude impact of exchange rate.
Minus factor Plus factor
959
（148）
190
181
1,397
213
11
Forecast for FYE Mar. 2017
(unit: JPY million)
FYE Mar. 2016 Result
FYE Mar. 2017 Forecast
Year-over-Year
Sales 57,636 56,000 (2.8%)
Operating Income 1,422 1,100 (22.7%)
Ordinary Income 1,252 1,200 (4.2%)
Profit attributable to owners of parent 754 900 19.3%
Net Income per share JPY 15.48 JPY 18.47 ---
Exchange Rate (average during period)
US Dollar 120.14 105.00
Euro 134.31 119.00
Singapore Dollar 86.70 76.00
(unit: JPY)
12
Topics < Apr. 2016 – Dec. 2016 > ※Announcement date
-”JMS Tongue Pressure Measuring Device” was adopted as the diagnostic criterion for “Deterioration of oral Function”. Dec. 2, 2016
-Launching new product “Oxia ACF” , Filter -integrated membrane oxygenator Jul. 21, 2016
-Holding the completion ceremony of the new facility of Izumo Plant. May. 6, 2016
-Holding the inauguration ceremony of JMS Healthcare PHL, Inc. . Apr. 25, 2016
JMS Tongue Pressure Measuring Device
13
The assessment figures described on this report are based on available information at this moment, including uncertain data. Actual results may be different from the figures.
The Bridge to Good Health Care
